Sage Therapeutics and Shionogi partner to develop antidepressant

15-06-2018

Sage Therapeutics and Shionogi partner to develop antidepressant

NicoElnino / iStockphoto.com

US-based biopharmaceutical company Sage Therapeutics and Japan-based pharmaceutical corporation Shionogi have entered into a strategic collaboration to develop an antidepressant drug.


Sage Therapeutics, Shionogi, antidepressant, big pharma, collaboration, drug development

LSIPR